Cargando…
Immunomodulation in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives
The heart failure (HF) epidemic is growing and approximately half of the HF patients have heart failure with preserved ejection fraction (HFpEF). HFpEF is a heterogeneous syndrome, characterized by a preserved left ventricular ejection fraction (LVEF ≥ 50%) with diastolic dysfunction, and is associa...
Autores principales: | Kessler, Elise L., Oerlemans, Martinus I.F.J., van den Hoogen, Patricia, Yap, Carmen, Sluijter, Joost P.G., de Jager, Saskia C.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892675/ https://www.ncbi.nlm.nih.gov/pubmed/32444946 http://dx.doi.org/10.1007/s12265-020-10026-3 |
Ejemplares similares
-
Clinical Phenotypes of Heart Failure With Preserved Ejection Fraction to Select Preclinical Animal Models
por: van Ham, Willem B., et al.
Publicado: (2022) -
Estrogen Contributions to Microvascular Dysfunction Evolving to Heart Failure With Preserved Ejection Fraction
por: Sickinghe, Ariane A., et al.
Publicado: (2019) -
Heart failure with preserved ejection fraction: current status and challenges for the future
por: van der Velden, J., et al.
Publicado: (2016) -
Heart failure with preserved ejection fraction: present status and future directions
por: Yoon, Somy, et al.
Publicado: (2019) -
Electrocardiographic Features of Left Ventricular Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Systematic Review
por: Van Ommen, Anne-Mar, et al.
Publicado: (2021)